News

Ira Goldknopf, president and chief scientific officer of Power3, said: “Power3 Medical is preparing to commercialize its BC SeraPro, and NuroPro tests for breast cancer, Alzheimer’s and Parkinson’s.

Natus has acquired all outstanding shares of NeuroCom capital stock for $18 million, exclusive of direct costs of the acquisition. Natus believes that the acquisition will be immediately

Dr Schafer is currently vice president of the Ultrasonic Industry Association, chairman of the National Electrical Manufacturers Association Ultrasound Technical Committee, and serves on the board of governors

Under the terms of the agreement, Lilly and Deciphera will collaborate in four different project areas involving selective or multi-kinase targeted B-Raf inhibitors. Lilly will obtain exclusive worldwide

The Lifepak 20e defibrillator/monitor offers all the capabilities of the Lifepak 20 device, along with a lithium-ion battery that doubles ECG monitoring time and the run time of

The grant, which is over three years, allows Ablynx to further develop technologies related to its Nanobody platform. Furthermore, this grant will enable Ablynx to expand its intellectual

Effective immediately, Covance will assume control of the Greenfield campus and 264 Lilly employees will be working for Covance.

Ms Carter will be a key member of Axcess’s executive management team responsible for the financial operations of the company and involved in overall corporate strategic planning. Steve

The Mirasol pathogen reduction technology (PRT) system is a proprietary technology that uses riboflavin and UV light to reduce the levels of infectious pathogens and inactivate white cells